HomeAKTX • NASDAQ
add
Akari Therapeutics PLC
Previous close
$0.35
Day range
$0.33 - $0.41
Year range
$0.26 - $1.72
Market cap
13.62M USD
Avg Volume
1.13M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 2.22M | 20.09% |
Net income | -6.40M | -121.07% |
Net profit margin | — | — |
Earnings per share | -0.03 | — |
EBITDA | -2.22M | -19.90% |
Effective tax rate | 14.53% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 2.48M | 10.60% |
Total assets | 45.38M | 1,559.69% |
Total liabilities | 22.69M | 140.66% |
Total equity | 22.69M | — |
Shares outstanding | 35.74M | — |
Price to book | 0.50 | — |
Return on assets | -11.55% | — |
Return on capital | -21.36% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -6.40M | -121.07% |
Cash from operations | -2.12M | -42.35% |
Cash from investing | — | — |
Cash from financing | 1.90M | 528.22% |
Net change in cash | -227.00K | 88.24% |
Free cash flow | -2.79M | -2,700.81% |
About
Founded
2004
Headquarters
Website
Employees
9
